ORGANICELL REGENERATIVE MEDICINE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

On May 25, 2021, Organicell issued a press release announcing that the Company will be presenting at the annual meeting of the International Society of Cell and Gene Therapy ("ISCT") taking place on May 26-28, 2021, the results of single patient IND studies.

The recently published manuscript on which the presentation is based can be read in full: https://www.frontiersin.org/articles/10.3389/fmed.2021.583842/full

A copy of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 7.01, including Exhibit 99.1 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

 (d) Exhibits




Exhibit No   Description
  99.1*      Press Release dated May 25, 2021





 * Furnished but not filed.

1

© Edgar Online, source Glimpses